INVESTOR NOTICE: Kaskela Law Firm Announces Stockholder Investigation of Agilon Health, Inc. (NYSE: AGL) and Encourages Long-Term AGL Stockholders to Contact the Firm - AGL

Core Viewpoint - Kaskela Law LLC is investigating potential breach of fiduciary duties claims against Agilon Health, Inc. on behalf of long-term investors due to alleged securities fraud and misleading statements regarding medical costs [1][2][4]. Group 1: Investigation Details - A securities fraud complaint has been filed against Agilon Health for making materially false and misleading statements to investors from April 15, 2021, to February 27, 2024 [2]. - The complaint alleges that Agilon Health and its senior executives misrepresented the company's medical costs, leading to significant financial losses for investors [2][3]. Group 2: Financial Impact - Agilon Health's stock price experienced a dramatic decline of approximately 85%, falling from over $44.00 per share to less than $6.50, resulting in a loss of over $38 per share during the relevant period [3]. Group 3: Legal Implications - The investigation aims to determine if Agilon's board of directors violated securities laws or breached fiduciary duties related to the alleged misconduct [4].